Did you know eyes can improve mental health
According to new study at the University of Missouri-Columbia, researchers took account of a person’s state of mind and found that a person’s eyes can ... Read More
Oral Contraceptives may increase risk of ischemic strokes in women
Oral Contraceptives, commonly known as birth control pills are known to block blood flow to the brain which may result in ischemic strokes. However, Ischemic ... Read More
Fresenius Kabi launches Omegaven for pediatric patients with parenteral nutrition-associated cholestasis in US
Fresenius Kabi, a prominent German pharmaceutical company, has introduced Omegaven (fish oil triglycerides) injectable emulsion in the United States, targeting a critical need for pediatric ... Read More
Millendo Therapeutics finalizes merger with OvaScience, strengthens rare disease pipeline
Millendo Therapeutics has finalized its merger with OvaScience, a Massachusetts-based biotech firm specializing in female infertility treatments. The transaction, initially announced in August 2018, concludes ... Read More
Novartis’ Kisqali plus endocrine therapy shows significant PFS benefits in advanced breast cancer trials
Swiss pharmaceutical giant Novartis has announced that its breast cancer drug, Kisqali (ribociclib), when used in combination with endocrine therapy, has demonstrated substantial efficacy in ... Read More
Health benefits of garlic oil for skin, hair and health problems
There are many unbelievable benefits of garlic oil for skin and health. In this post, we will discuss about the best uses of garlic oil ... Read More
New nasal spray shows promise in treating sleep apnoea
Sleep apnoea, commonly associated with snoring, is a serious health condition where the throat tissue collapses and blocks the airway for about ten seconds during ... Read More
Mirum Pharmaceuticals raises $120m to advance Maralixibat for rare liver diseases
Mirum Pharmaceuticals, a clinical-stage pharmaceutical company, has successfully raised $120 million in a Series A funding round to propel the development of its lead drug, ... Read More
Novartis secures EC approval for Gilenya in pediatric multiple sclerosis treatment
Novartis has announced that the European Commission has expanded the approval of its multiple sclerosis drug, Gilenya (fingolimod), to include the treatment of children and ... Read More
Pfizer, AbbVie settle global IP for Humira biosimilar, paving way for European launch
In a significant step towards expanding biosimilar access, Pfizer and AbbVie have resolved all global intellectual property disputes concerning Pfizer’s proposed biosimilar to AbbVie’s blockbuster ... Read More